Text size Sage is in a partnership with Biogen on zuranalone. Dreamstime Sage Therapeutics said early Tuesday that its drug zuranalone reduced depression symptoms in a Phase 3 trial, but the results seem to have befuddled investors. The stock fell as low as $57 in premarket trading from $72.86 at the market close on Monday, […]
Sage’s Depression Drug Zuranalone Worked. Here’s Why the Stock Is Falling. Read More »
Potential for FDA 505(b)(2) regulatory pathway approval and FDA Fast Track designation Advancing Ketamine and KETABET™ alone or in a microneedle patch for intradermal administration Potential next generation treatment for mental health, neurological and pain disorders TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Read More »
Looking to make a comeback after a big Phase III flop, Sage Therapeutics revealed data they believe could change the entire depression treatment landscape, given the vast array of failures in the field. But some results are spooking investors, sending Sage $SAGE shares down early Tuesday. First, the primary: Sage and Biogen reported Phase III
In 2015, University of Chicago Prof. Peter Nagele became interested in exploring the effects of nitrous oxide, commonly known as “laughing gas”—not for dental procedures, as most people associate it with, but for treating severe depression. A new study by Nagele and colleagues at UChicago and Washington University in St. Louis found that a single inhalation
Low doses of ‘laughing gas’ could be effective in treating severe depression Read More »
Study data published in JAMA support the efficacy of a digital intervention for depressive symptoms among patients with hypertension or diabetes. In randomized clinical trials (RCTs) conducted in Brazil and Peru, patients displayed significant improvements in depression symptoms following digital treatment. However, results were not sustained at 6 months. Depression is a known risk factor
June 14 (Reuters) – Tropical Depression Two has formed off the coast of North Carolina and is heading away from the United States, the U.S. National Hurricane Center (NHC) said on Monday. The depression is located about 105 miles (165 km) east of Cape Hatteras, North Carolina, packing maximum sustained winds of 35 miles per
Tropical Depression Two forms off North Carolina coast: NHC Read More »
Teachers are almost twice as likely to experience frequent job-related stress and nearly three times as likely to experience symptoms of depression than the general adult population, a new survey finds. These results—which are alarming but perhaps not surprising—were reported by RAND Corp. researchers, who fielded a nationally representative survey of teachers in late January
Teachers Are More Likely to Experience Depression Symptoms Than Other Adults Read More »
(WNDU) – A former Notre Dame hockey star is starting a long journey. Former Irish Icers alternate captain Stephen Johns announced his retirement from hockey, and that he is tackling a new adventure. Johns has noted he has battled depression for years, and wants to help others facing the same fight. “What I’ll miss most
NEW ORLEANS (WVUE) – A tropical disturbance currently located in the far southern Gulf and Bay of Campeche is being monitored for tropical development over the coming days. At this time there is little to no organization with the system in the Bay of Campeche. It is still way too early to give specific impacts
Gulf system likely to become tropical depression; heavy rainfall the biggest threat Read More »
Q: My husband was in the hospital for three weeks with COVID-19. He’s home again and seems OK physically, but he’s not the same person. He’s withdrawn and angry, and I think he’s depressed. He won’t talk about it to me or our kids. What can we do? A: We’re very glad to hear that
Many COVID-19 survivors will develop depression Read More »